Phase IIb Protocol 011: Islatravir Plus Doravirine Following Islatravir, Doravirine, Lamivudine Induction in Treatment-Naive Patients Demonstrates Very Low HIV-1 RNA Levels in Patients With Wk 48 Protocol-Defined Virologic Failure

Download expert-authored CCO slides reviewing data and guidelines on management of heavily-treatment experienced patients with HIV

Joseph J. Eron, Jr., MD
Program Director Princy N. Kumar, MD, FIDSA, MACP
Program Director Eric S. Daar, MD Released: March 2, 2021

Download CCO slides reviewing data and guidelines on management of heavily-treatment experienced patients with HIV experiencing treatment failure

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: February 22, 2021

Expert commentary on managing a TB outbreak in a socially and medically complex population of patients living with HIV

Nicky Mehtani, MD, MPH Released: February 22, 2021

Multimedia module from Clinical Care Options: HIV experts review new/emerging strategies for initial HIV treatment, switching ART, and HIV prevention

Joseph J. Eron, Jr., MD
Program Director Princy N. Kumar, MD, FIDSA, MACP
Program Director Daniel R. Kuritzkes, MD Paul E. Sax, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: December 30, 2020 Expired: December 29, 2021

Rapid ART Initiation (12 minutes)

Evolving Issues in First-line Combination Therapy (30 minutes)

Evolving Options for Switch Therapy (18 minutes)

Integrating a New PrEP Option (10 minutes)

Questions and Answers (7 minutes)